These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 2377105)

  • 1. The injecting and sexual behaviour of intravenous drug users in Sydney.
    Dinnen A
    Med J Aust; 1990 Jun; 152(12):672. PubMed ID: 2377105
    [No Abstract]   [Full Text] [Related]  

  • 2. High HIV testing and low HIV prevalence among injecting drug users attending the Sydney Medically Supervised Injecting Centre.
    Salmon AM; van Beek I; Amin J; Grulich A; Maher L
    Aust N Z J Public Health; 2009 Jun; 33(3):280-3. PubMed ID: 19630850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and risk factors for hepatitis C seroconversion in injecting drug users in Australia.
    Maher L; Jalaludin B; Chant KG; Jayasuriya R; Sladden T; Kaldor JM; Sargent PL
    Addiction; 2006 Oct; 101(10):1499-508. PubMed ID: 16968352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence rates and risk factors for hepatitis C among drug users not in treatment in Malaysia.
    Vicknasingam B; Narayanan S; Navaratnam V
    Drug Alcohol Rev; 2009 Jul; 28(4):447-54. PubMed ID: 19594801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The injecting and sexual behaviour of intravenous drug users.
    Dinnen A
    Med J Aust; 1991 Jan; 154(2):152. PubMed ID: 1986198
    [No Abstract]   [Full Text] [Related]  

  • 6. Hepatitis C prevalence and risk behavior of injecting drug users in Sydney: a continuing concern.
    Habib SE; Lovejoy FH; Aspin C
    Southeast Asian J Trop Med Public Health; 2001 Dec; 32(4):823-34. PubMed ID: 12041560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C virus among self declared non-injecting sexual partners of injecting drug users.
    Roy KM; Goldberg DJ; Hutchinson S; Cameron SO; Wilson K; MacDonald L
    J Med Virol; 2004 Sep; 74(1):62-6. PubMed ID: 15258969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroprevalence of and risk factors for HIV-1 infection in injection drug users in Montreal and Toronto: a collaborative study.
    Lamothe F; Bruneau J; Coates R; Rankin JG; Soto J; Arshinoff R; Brabant M; Vincelette J; Fauvel M
    CMAJ; 1993 Oct; 149(7):945-51. PubMed ID: 8402423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly active antiretroviral therapy (HAART) among HIV-infected drug users: a prospective cohort study of sexual risk and injecting behaviour.
    Smit C; Lindenburg K; Geskus RB; Brinkman K; Coutinho RA; Prins M
    Addiction; 2006 Mar; 101(3):433-40. PubMed ID: 16499516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparations for AIDS vaccine trials. Retention, behavior change, and HIV-seroconversion among injecting drug users (IDUs) and sexual partners of IDUs.
    Marmor M; Titus S; Wolfe H; Krasinski K; Maslansky R; Simberkoff M; Beatrice S; Nichols S; Des Jarlais DC
    AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S207-13. PubMed ID: 7865302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poor knowledge and low coverage of hepatitis B vaccination among injecting drug users in Sydney.
    Day C; White B; Ross J; Dolan K
    Aust N Z J Public Health; 2003 Oct; 27(5):558. PubMed ID: 14651407
    [No Abstract]   [Full Text] [Related]  

  • 12. HIV risk behaviors and HIV seropositivity among young injection drug users.
    Marrero Rodríguez CA; Robles RR; Colón HM; Freeman DH; Matos TD; Reyes JC
    P R Health Sci J; 1993 Apr; 12(1):7-12. PubMed ID: 8511250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The difference between men and women drug users in seroconversion risk factors].
    Strathdee SA; Galai N; Safaiean M; Celentano DD; Vlahov D; Johnson L; Nelson KE
    Sidahora; 2001 Aug; ():25-6. PubMed ID: 11681272
    [No Abstract]   [Full Text] [Related]  

  • 14. The injecting and sexual behaviour of intravenous drug users in Sydney.
    Darke S; Hall W; Carless J
    Med J Aust; 1990 Apr; 152(8):446. PubMed ID: 2329953
    [No Abstract]   [Full Text] [Related]  

  • 15. HIV antibodies among intravenous drug users in Bahrain.
    al-Haddad MK; Khashaba AS; Baig BZ; Khalfan S
    J Commun Dis; 1994 Sep; 26(3):127-32. PubMed ID: 7868834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mode of HIV transmission among seroconverted intravenous drug users (IVDUs): 1987 and 1988 cohort study.
    Nemoto T; Brown LS; Primm BJ; Foster K; Chu A
    NIDA Res Monogr; 1989; 95():407-8. PubMed ID: 2641011
    [No Abstract]   [Full Text] [Related]  

  • 17. Needle-sharing patterns as a predictor of HIV seroprevalence among New York City intravenous drug users (IVDUs).
    Yee K; Brown LS; Primm BJ; Nemoto T; Foster K
    NIDA Res Monogr; 1989; 95():488-9. PubMed ID: 2641040
    [No Abstract]   [Full Text] [Related]  

  • 18. The injecting and sexual behaviour of intravenous drug users in Sydney.
    Guinan JJ; Gold J
    Med J Aust; 1990 Oct; 153(8):503-4. PubMed ID: 2215351
    [No Abstract]   [Full Text] [Related]  

  • 19. [The survey of HIV prevalence among drug users in Guangxi, China].
    Zhang G; Zheng X; Liu W; Liang F; Qu S; Mao Y; Wang L; Chen J
    Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Feb; 21(1):15-6. PubMed ID: 11860749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unlinked anonymous monitoring of HIV prevalence in England and Wales: 1990-92.
    Commun Dis Rep CDR Rev; 1993 Jan; 3(1):R1-11. PubMed ID: 7689016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.